Based on FMI’s analysis, the high-flow oxygen therapy devices market is anticipated to develop at a compound annual growth rate (CAGR) of 0.5% during the predicted period. It is projected that the industry would be valued at US$ 1,494.8 million on the market in 2023.The market is projected to be positively influenc.
INDIANA - Hamilton Medical, Inc. is recalling the HAMILTON-C1, T1, MR-1 ventilators because the capacitators may leak electrolyte fluid onto the ventilator’s control board. If the control board contacts the electrolyte fluid, the control board or installed spare parts could short circuit. As a r .
DUBAI, United Arab Emirates, The rising prevalence of acute respiratory failures due to the COVID-19 outbreak, risk of community infection, increasing demand for high flow nasal cannula, and advancements in high Flow Oxygen Therapy Devices are some key factors contributing to the growth of the high flow oxygen therapy devices market.